Cargando…
Verticillin A Inhibits Leiomyosarcoma and Malignant Peripheral Nerve Sheath Tumor Growth via Induction of Apoptosis
OBJECTIVE: The heterogeneity of soft tissue sarcoma (STS) represents a major challenge for the development of effective therapeutics. Comprised of over 50 different histology subtypes of various etiologies, STS subsets are further characterized as either karyotypically simple or complex. Due to the...
Autores principales: | Zewdu, A, Lopez, G, Braggio, D, Kenny, C, Constantino, D, Bid, HK, Batte, K, Iwenofu, OH, Oberlies, NH, Pearce, CJ, Strohecker, AM, Lev, D, Pollock, RE |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295762/ https://www.ncbi.nlm.nih.gov/pubmed/28184331 http://dx.doi.org/10.4172/2161-1459.1000221 |
Ejemplares similares
-
Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma: Preclinical correlates
por: Lopez, Gonzalo, et al.
Publicado: (2017) -
HDAC8, A Potential Therapeutic Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors (MPNST)
por: Lopez, Gonzalo, et al.
Publicado: (2015) -
Media studies to enhance the production of verticillins facilitated by in situ chemical analysis
por: Amrine, Chiraz Soumia M., et al.
Publicado: (2018) -
β-catenin S45F mutation results in apoptotic resistance
por: Braggio, Danielle, et al.
Publicado: (2020) -
miR-133a function in the pathogenesis of dedifferentiated liposarcoma
por: Yu, Peter Y., et al.
Publicado: (2018)